Literature DB >> 6154839

Discontinuation syndrome following cessation of treatment with clonidine and other antihypertensive agents.

M A Weber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6154839     DOI: 10.1097/00005344-198000021-00008

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


× No keyword cloud information.
  11 in total

1.  In vitro and in vivo down-regulation of human platelet alpha 2-adrenoceptors by clonidine.

Authors:  O E Brodde; M Anlauf; N Graben; K D Bock
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

2.  New aspects of the pharmacokinetics and pharmacodynamics of clonidine in man.

Authors:  D Arndts; J Doevendans; R Kirsten; B Heintz
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 3.  Clinical consequences of abrupt drug withdrawal.

Authors:  C F George; D Robertson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct

4.  Temporal linear mode complexity as a surrogate measure of the effect of remifentanil on the central nervous system in healthy volunteers.

Authors:  Byung-Moon Choi; Da-Huin Shin; Moon-Ho Noh; Young-Hac Kim; Yong-Bo Jeong; Soo-Han Lee; Eun-Kyung Lee; Gyu-Jeong Noh
Journal:  Br J Clin Pharmacol       Date:  2011-06       Impact factor: 4.335

5.  Drug withdrawal and rebound hypertension: differential action of the central antihypertensive drugs moxonidine and clonidine.

Authors:  H Rupp; B Maisch; C G Brilla
Journal:  Cardiovasc Drugs Ther       Date:  1996-06       Impact factor: 3.727

6.  Concentration-effect and time-effect relationships of carteolol.

Authors:  T Ishizaki; A Ohnishi; T Sasaki; K Chiba; T Suganuma; K Kushida
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Guanfacine and clonidine: antihypertensive and withdrawal characteristics after continuous infusion and its interruption in the spontaneously hypertensive and normotensive rat.

Authors:  M J Thoolen; P B Timmermans; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-04       Impact factor: 3.000

Review 8.  Clinical pharmacokinetics of clonidine.

Authors:  D T Lowenthal; K M Matzek; T R MacGregor
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

Review 9.  Pharmacological management of hypertension in paediatric patients. A comprehensive review of the efficacy, safety and dosage guidelines of the available agents.

Authors:  K Miller
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

10.  Crossover comparison of moxonidine and clonidine in mild to moderate hypertension.

Authors:  V Plänitz
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.